Accueil・Liste d'Actions・Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Ouvert

13.97 4.33

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.35

Max

14.06

Chiffres clés
By Trading Economics
Revenu	-1.4M -14M
BPA	-0.15
Employés	37
EBITDA	312K -12M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+136.35% upside

Dividendes
By Acuity
Prochains Résultats	6 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-261M 1.1B
Ouverture précédente	9.64
Clôture précédente	13.97

Corvus Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 août 2026, 23:56 UTC

Full Truck Alliance Co Ltd. is trading higher in after-market hours, reflecting routine fluctuations within a narrow range above its 20-day moving average.

3 août 2026, 23:56 UTC

State Street Corp shares are trading lower in after-market hours, following a modest decline after Monday's regular session close.

3 août 2026, 23:56 UTC

Pentair PLC shares are lower in after-market hours with no specific news driving the decline. The stock remains within its one-month trading range.

3 août 2026, 23:56 UTC

News

Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.

3 août 2026, 23:56 UTC

Correlated Moves

Masco Corp shares are higher in after-market trading, supported by a notable rise in JELD-WEN Holding Inc. The stock remains near its one-month range low.

3 août 2026, 23:56 UTC

Stanley Black & Decker shares are higher in after-market trading, supported by positive market sentiment and easing inflation concerns amid declining oil prices.

3 août 2026, 23:56 UTC

Correlated Moves

Microstrategy Inc shares declined after market hours, reaching a low of -1.10%. The drop may be influenced by Bitcoin's recent decline.

3 août 2026, 23:56 UTC

Chewy Inc. shares are trading higher in after-market hours, rebounding from a brief dip following Monday's close amid broader positive market sentiment.

3 août 2026, 23:56 UTC

Kroger Co shares are lower in after-market trading, retracing from an earlier rise and settling around the midpoint of their one-month trading range.

3 août 2026, 23:56 UTC

MGM Resorts International shares are higher in after-market hours, continuing modest gains since Monday's close amid positive sentiment in European markets.

3 août 2026, 23:56 UTC

Equinix Inc shares are higher in after-market hours, reflecting broader market strength amid gains in European indices and falling oil prices.

3 août 2026, 23:56 UTC

Correlated Moves

Martin Marietta Materials shares are higher in after-market trading, supported by positive market sentiment and correlated gains in nVent Electric PLC.

3 août 2026, 23:56 UTC

Incyte Corp shares are higher in after-market hours, recovering from five consecutive daily declines. Broader market sentiment remains positive amid declining oil prices.

3 août 2026, 23:56 UTC

Brown & Brown Inc shares are trading lower in after-market hours, following a session that included an early spike before a steady decline.

3 août 2026, 23:56 UTC

AutoZone Inc shares are trading higher in after-market hours, recovering from a dip after Monday's close with no specific news identified for the movement.

3 août 2026, 23:56 UTC

J M Smucker Co shares are higher in after-market hours, recovering from earlier declines and remaining above their 20-day moving average. No specific news was identified.

3 août 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is trading roughly flat in after-market hours, supported by LI's positive return and JD's slight decline.

3 août 2026, 23:56 UTC

Correlated Moves

NIO Inc shares are higher in after-market trading, reflecting positive sentiment in the electric vehicle sector. Xpeng Inc also saw a price increase.

3 août 2026, 23:56 UTC

JPMorgan Chase & Co shares are higher in after-market hours, supported by positive sentiment in European markets. The asset remains above its 20-day moving average.

3 août 2026, 23:56 UTC

Bath & Body Works Inc. shares declined slightly in after-market trading, reflecting routine fluctuations despite remaining above the 20-day moving average.

3 août 2026, 23:56 UTC

News

First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.

3 août 2026, 23:56 UTC

Cisco Systems Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The broader market showed mixed signals.

3 août 2026, 23:56 UTC

Indie Semiconductor Inc. shares are higher in after-market trading, showing modest gains since Monday's close amid positive broader market sentiment.

3 août 2026, 23:56 UTC

Correlated Moves

Riot Platforms Inc. is higher in after-market hours, recovering from an initial dip. Positive sentiment in European indices supports cryptocurrency-related stocks.

3 août 2026, 23:56 UTC

Correlated Moves

Kosmos Energy Ltd shares are higher in after-hours trading, reflecting positive sentiment in the energy sector and influenced by Crescent Energy's notable gains.

3 août 2026, 23:56 UTC

New Fortress Energy Inc shares are higher in after-market trading, reflecting a recovery from earlier lows amid positive sentiment in European markets.

3 août 2026, 23:56 UTC

Macro News

Crude oil prices are lower as President Trump called off a military strike on Iran, boosting optimism for stability in the Middle East.

3 août 2026, 23:52 UTC

Social Media

Correlated Moves

News

Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.

3 août 2026, 23:51 UTC

Schneider National shares higher in after-market trading, reflecting notable strength since Monday's close despite remaining below the 20-day moving average.

3 août 2026, 23:51 UTC

Shake Shack Inc. shares declined after-market, contrasting with gains in major U.S. tech stocks. The asset remains above its 20-day moving average.

Comparaison

Variation de prix

Corvus Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

136.35% hausse

Prévisions sur 12 Mois

Moyen 31.6 USD 136.35%

Haut 40 USD

Bas 27 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.